-
2
-
-
0036197584
-
Performance of the new Bayer VERSANT HCV RNA 3.0 assay for quantitation of hepatitis C virus RNA in plasma and serum: Conversion to international units and comparison with the Roche COBAS Amplicor HCV Monitor, Version 2.0 assay
-
(2002)
J. Clin. Microbiol.
, vol.40
, pp. 788-793
-
-
Beld, M.1
Sentjens, R.2
Rebers, S.3
Weegink, C.4
Weel, J.5
Sol, C.6
Boom, R.7
-
4
-
-
0036136411
-
Evolutionary trends of the first hypervariable region of the hepatitis C virus E2 protein in individuals with differing liver disease severity
-
(2002)
J. Gen. Virol.
, vol.83
, pp. 11-23
-
-
Curran, R.1
Jameson, C.A.2
Craggs, J.K.3
Grabowska, A.M.4
Robins, A.5
Thomson, B.J.6
Irving, W.L.7
Ball, J.K.8
-
7
-
-
0034858270
-
Specificity of the inflammatory mononuclear cell infiltrate in hepatiits C virus-infected liver disease
-
(2001)
Eur. J. Immunol.
, vol.31
, pp. 2388-2394
-
-
Grabowska, A.1
Lechner, F.2
Klenerman, P.3
Tighe, P.4
Ryder, S.5
Ball, J.6
Thomson, B.7
Irving, W.L.8
Robbins, A.9
-
15
-
-
0032910634
-
Transmission rates of hepatitis C virus by different batches of a contaminated anti-D immunoglobulin preparation
-
(1999)
Vox Sang
, vol.76
, pp. 138-143
-
-
Lawlor, E.1
Power, J.2
Garson, J.3
Yap, P.4
Davidson, F.5
Columb, G.6
Smith, D.7
Pomeroy, L.8
O'Riordan, J.9
Simmonds, P.10
Tedder, R.11
-
16
-
-
0001400947
-
Prognostic factors and early predictability of sustained viral response (SVR) in patients treated with pegylated (40 kDa) interferonalfa-2a (Pegasys): A new profile
-
(2000)
Hepatology
, vol.32
-
-
Lee, S.1
-
17
-
-
0032547938
-
Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C
-
(1998)
New Engl. J. Med.
, vol.339
, pp. 1485-1492
-
-
McHutchison, J.G.1
Gordon, S.C.2
Schiff, E.R.3
Shiffman, M.L.4
Lee, W.M.5
Rustgi, V.K.6
Goodman, Z.D.7
Ling, M.-H.8
Cort, S.9
Albrecht, J.K.10
-
18
-
-
0035039269
-
The epidemiology of hepatitis C in a UK Health Regional population of 5.12 million
-
(2001)
Gut
, vol.48
, pp. 707-713
-
-
Mohsen, A.1
-
19
-
-
0031749658
-
What strategy should be used for diagnosis of hepatitis C virus infection in clinical laboratories
-
(1998)
Hepatology
, vol.27
, pp. 1700-1702
-
-
Pawlotsky, J.M.1
Lonjon, I.2
Hezode, C.3
Raynard, B.4
Darthuy, F.5
Remire, J.6
Soussy, C.J.7
Dhumeaux, D.8
-
20
-
-
0032585237
-
Randomised trial of interferon α2b plus ribavirin for 48 weeks or for 24 weeks versus interferon α2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus
-
(1998)
Lancet
, vol.352
, pp. 1426-1432
-
-
Poynard, T.1
Marcellin, P.2
Lee, S.S.3
Niederau, C.4
Minuk, G.S.5
Ideo, G.6
Bain, V.7
Heathcote, J.8
Zeuzem, S.9
Trepo, C.10
Albrecht, J.11
-
24
-
-
0031968864
-
Hepatitis C virus infections in dialysis centers in The Netherlands: A national survey by serological and molecular methods
-
(1998)
J. Clin. Microbiol.
, vol.36
, pp. 1711-1715
-
-
Schneeberger, P.M.1
Keur, I.2
Van der Vliet, W.3
Van Hoek, K.4
Boswijk, H.5
Van Loon, A.M.6
Van Dijk, W.C.7
Kauffmann, R.H.8
Quint, W.9
Van Doorn, L.J.10
-
25
-
-
0033016820
-
Real-time detection system for quantification of hepatitis C virus genome
-
(1999)
Gastroenterology
, vol.116
, pp. 636-642
-
-
Takeuchi, T.1
Katsume, A.2
Tanaka, T.3
Abe, A.4
Inoue, K.5
Tsukiyama-Kohara, K.6
Kawaguchi, R.7
Tanaka, S.8
Kohara, M.9
-
26
-
-
19144371869
-
Simple fluorescent enzyme immunoassay for detection and quantification of hepatitis C viraemia
-
(1995)
J. Hepatol.
, vol.26
, pp. 742-745
-
-
Tanaka, T.1
Lau, J.Y.2
Mikokami, M.3
Orito, E.4
Tanaka, R.5
Kiyosawa, K.6
Yasui, K.7
Ohta, Y.8
Hasegawa, A.9
Tanaka, S.10
Kahawa, H.11
|